---
title: "Sanara MedTech Inc. (SMTI.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/SMTI.US.md"
symbol: "SMTI.US"
name: "Sanara MedTech Inc."
industry: "Health Care Supplies"
---

# Sanara MedTech Inc. (SMTI.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Location | US Market |
| Website | [anaramedtech.com](https://anaramedtech.com) |

## Company Profile

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bov...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-21T04:30:14.000Z

**Overall: C (0.52)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 24 / 43 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 30.52% |  |
| Net Profit YoY | -348.29% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 29.72 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 182.73M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 101.88M |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -26.46% | E |
| Profit Margin | -36.80% | E |
| Gross Margin | 92.88% | A |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 30.52% | A |
| Net Profit YoY | -348.29% | E |
| Total Assets YoY | -19.72% | E |
| Net Assets YoY | -84.44% | E |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -271.74% | D |
| OCF YoY | 30.52% | A |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 1.28 | A |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 91.36% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Sanara MedTech Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-26.46%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-36.80%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "92.88%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "30.52%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-348.29%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-19.72%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-84.44%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-271.74%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "30.52%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "1.28",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "91.36%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Essilor (US.ESLOY) | B | B | C | B | B | B |
| 02 | HOYA Corporation (US.HOCPY) | A | B | B | A | C | B |
| 03 | Align (US.ALGN) | B | C | B | B | C | B |
| 04 | Merit Medical (US.MMSI) | B | B | B | C | B | B |
| 05 | UFP Tech (US.UFPT) | B | B | A | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -4.87 | 33/45 | - | - | - |
| PB | 29.72 | 38/45 | 29.86 | 7.55 | 6.93 |
| PS (TTM) | 1.79 | 17/45 | 3.10 | 2.79 | 2.08 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-26T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 20.45 |
| Highest Target | 44.00 |
| Lowest Target | 36.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/SMTI.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/SMTI.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/SMTI.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.